Klein Pavlis & Peasley Financial, Inc. Abbott Laboratories Transaction History
Klein Pavlis & Peasley Financial, Inc.
- $150 Billion
- Q2 2025
A detailed history of Klein Pavlis & Peasley Financial, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Klein Pavlis & Peasley Financial, Inc. holds 17,000 shares of ABT stock, worth $2.23 Million. This represents 1.54% of its overall portfolio holdings.
Number of Shares
17,000Holding current value
$2.23 Million% of portfolio
1.54%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,578Shares Held
1.38BCall Options Held
9.76MPut Options Held
9.19M-
Vanguard Group Inc Valley Forge, PA173MShares$22.7 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.2 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.78 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.66 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $230B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...